Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5CLM

1,4-Oxazine BACE1 inhibitors

5CLM の概要
エントリーDOI10.2210/pdb5clm/pdb
分子名称Beta-secretase 1, N-{3-[(3R)-5-amino-3-methyl-3,6-dihydro-2H-1,4-oxazin-3-yl]phenyl}-5-chloropyridine-2-carboxamide, IODIDE ION, ... (5 entities in total)
機能のキーワードbace1 protease inhibitor, orally bioavailable, brain penetrant, proteros biostructures gmbh, hydrolase
由来する生物種Homo sapiens (Human)
細胞内の位置Membrane; Single-pass type I membrane protein: P56817
タンパク質・核酸の鎖数1
化学式量合計45389.01
構造登録者
主引用文献Rombouts, F.J.,Tresadern, G.,Delgado, O.,Martinez-Lamenca, C.,Van Gool, M.,Garcia-Molina, A.,Alonso de Diego, S.A.,Oehlrich, D.,Prokopcova, H.,Alonso, J.M.,Austin, N.,Borghys, H.,Van Brandt, S.,Surkyn, M.,De Cleyn, M.,Vos, A.,Alexander, R.,Macdonald, G.,Moechars, D.,Gijsen, H.,Trabanco, A.A.
1,4-Oxazine beta-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads.
J.Med.Chem., 58:8216-8235, 2015
Cited by
PubMed Abstract: 1,4-Oxazines are presented, which show good in vitro inhibition in enzymatic and cellular BACE1 assays. We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site. Our strategy permitted modulation of properties such as permeation and especially P-glycoprotein efflux. This led to compounds which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, respectively, in mouse and dog models. The amyloid lowering potential of these molecules makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.
PubMed: 26378740
DOI: 10.1021/acs.jmedchem.5b01101
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.61 Å)
構造検証レポート
Validation report summary of 5clm
検証レポート(詳細版)ダウンロードをダウンロード

247035

件を2026-01-07に公開中

PDB statisticsPDBj update infoContact PDBjnumon